Pfizer Inc. PFE
$27.93
+0.52%
at last close
Market Cap$160.96 billion
P/E Ratio36.76
Div Yield6.16%
Volume26.43M
52-Week Range
$23.11$28.75
Analyst Ratings
- Consensus
- Hold — 5 Buy · 8 Hold · 1 Sell (14 analysts)
- Avg. Price Target
- $28.79 (+3.0% upside)
Key Stats
- Today's Range
- $27.66 – $28.43
- 50-Day Range
- $23.62 – $28.43
- 52-Week Range
- $23.11 – $28.75
- Volume
- 26.43 million shs
- Average Volume
- 39.81 million shs
- Market Cap
- $160.96 billion
- P/E Ratio
- 36.76
- Dividend Yield
- 6.16%
Valuation
- P/E Ratio
- 36.76
- Price / Book
- 1.88
- Price / Sales
- 2.53
Dividend
- Dividend Yield
- 6.16%
- Annual Dividend
- $1.72
- Payout Ratio
- 226.32%
- Ex-Dividend Date
- 2026-07-24
Short Interest
- Short Interest
- 0.88%
- Days to Cover
- 4.22
Financials (TTM)
- Revenue
- $63.70 billion
- Net Income
- $4.37 billion
- Net Margin
- 6.86%
- Return on Equity
- 5.11%
- Debt-to-Equity
- —
About Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Related Stocks
Compare head-to-head: PFE vs LLY·PFE vs JNJ·PFE vs ABBV·PFE vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.